#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Non-Hodgkin's lymphoma refractory Myeloproliferative neoplasm Immunodeficiency congenital Meningitis meningococcal Pulmonary hypertension Round cell liposarcoma Conjunctivitis allergic Metabolic disorder Glioblastoma multiforme Graft versus host disease Progressive multifocal leukoencephalopathy Leukoencephalopathy Anti-myelin-associated glycoprotein associated polyneuropathy Short-bowel syndrome Idiopathic pulmonary fibrosis More trials…

    Learn about Rare Diseases

    Cystic fibrosis – Basic Information Paraneoplastic neurological syndrome – Treatment X-linked lymphoproliferative syndrome – Life with Disease SAPHO syndrome – Diagnostics Medulloblastoma KBG syndrome – Trials in Disease Phenylketonuria – Diagnostics Haemolytic uraemic syndrome – Trials in Disease Mucopolysaccharidosis – Life with Disease Sjogren’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Skb264 Anitocabtagene Autoleucel Temocillin Sodium Gs-4182 Lacosamide Lactose Monohydrate Clonazepam Clindamycin Piflufolastat (18F) Piperacillin Monohydrate Alanyl Glutamine Pentixafor Gallium Ga-68 Zolbetuximab LVT-001 Fluorouracil Laronidase Octocog Alfa Adezunap Efinopegdutide Cabotegravir Sodium More therapies…

    Learn about Your Condition

    Deafness bilateral Alpha-1 antitrypsin deficiency Biliary neoplasm Haemodynamic instability Colour blindness Acromegaly Myeloproliferative neoplasm Metachromatic leukodystrophy Dizziness External cephalic version Arrhythmia supraventricular CADASIL Pelvic venous thrombosis Menopausal symptoms Ischaemic stroke More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Ovarian cancer

  • Study of DS-3939a for Patients with Advanced or Metastatic Solid Tumors

    Recruiting

    2 1 1
    Investigated Diseases:
    • Biliary cancer metastatic
    • Breast cancer recurrent
    • Breast cancer stage IV
    Investigated Drugs:
    • Ds-3939A
    Belgium France Spain

  • Study on Dostarlimab and Niraparib for Patients with Metastatic or Recurrent Endometrial or Ovarian Carcinosarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Endometrial cancer
    • Endometrial cancer recurrent
    • Ovarian cancer
    Investigated Drugs:
    • Dostarlimab
    • Niraparib Tosilate Monohydrate
    France Italy Spain

  • Study on the Effects of Tinzaparin on Biomarkers in Advanced Ovarian Cancer Patients Receiving Chemotherapy

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer stage IV
    • Ovarian cancer stage III
    • Ovarian cancer
    Investigated Drugs:
    • Tinzaparin Sodium
    Sweden

  • Phase I/II Study of ubamatamab plus drug combination in patients with ovarian cancer who have poor response to first‑line chemotherapy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Ovarian cancer
    Investigated Drugs:
    • Filgrastim
    • Ubamatamab
    • Bevacizumab
    France

  • DB-1311 in Combination with BNT327 or DB-1305 for Patients with Advanced or Metastatic Solid Tumors

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Malignant melanoma
    • Cervix carcinoma
    • Hepatocellular carcinoma
    Investigated Drugs:
    • HUMANISED IGG1 MONOCLONAL ANTIBODY AGAINST TROP2 CONJUGATED TO N-((7S,15S)-7-BENZYL-17-(((1S,9S)-9-ETHYL-5-FLUORO-9-HYDROXY-4-METHYL-10,13-DIOXO-2,3,9,10,13,15-HEXAHYDRO-1H,12H-BENZO[DE]PYRANO[3′,4′:6,7] INDOLIZINO[1,2-B]QUINOLIN-1-YL)AMINO)-15-METHYL-2,5,8,11,17-PENTAOXO-14-OXA-3,6,9,12-TETRAAZAHEPTADECYL)-6-(2,5-DIOXO-2,5-DIHYDRO-1H-PYRROL-1-YL)HEXANAMIDE
    • BNT327
    France Germany Italy Poland Spain

  • A study to evaluate the safety of SGN-ALPV in patients with advanced solid tumors

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Testicular germ cell cancer
    • Endometrial cancer
    • Cervix carcinoma
    Investigated Drugs:
    • SGN-ALPV
    Denmark The Netherlands Spain Sweden
Previous Page
1 … 6 7 8 9 10 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!